Product Description
The Chinese dental implant and final abutment market was valued at nearly $604 million in 2024. This is expected to increase over the forecast period at a CAGR of 11.6% to reach over $1.3 billion.
The full report suite on the Chinese market for dental implants and final abutments includes dental implants, final abutments, treatment planning software and surgical guides.
DATA TYPES INCLUDED IN THIS REPORT
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Market Drivers & Limiters
- Market Forecasts Until 2031, and Historical Data to 2021
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
CHINESE DENTAL IMPLANT MARKET TRENDS
CHINESE DENTAL IMPLANT MARKET SHARE INSIGHTS
- The Straumann Group was the leading competitor in the dental implant and final abutment market in 2024. The company benefits from strong brand recognition and a proven track record of developing best-in-class dental implants. Historically, Straumann has dominated the premium implant segment, driven by a comprehensive suite of dental-implant-associated products that support a wide range of clinical applications. Its subsidiary, Neodent, has also outperformed the market average in the value implant segment, further reinforcing Straumann’s position as a clear leader in the overall dental implant market. With a sustained focus on mergers and acquisitions, Straumann has significantly enhanced its global profile and is well positioned to maintain its leadership in the industry.
- Osstem Implant was the second-leading competitor in the dental implant and final abutment market in China in 2024. The company has achieved strong brand recognition in the Chinese market, supported in large part by its dental implant education programs conducted in collaboration with the Advanced Dental Implant Research & Education Center (AIC). Osstem offers three main implant systems: the ET Implant System, the MS Implant System and the SS Implant System. Beyond its implant and abutment portfolios, the company also provides regenerative solutions, guided surgery systems, dental materials and select dental operatory equipment, including dental chairs.
- Envista, through its brand Nobel Biocare, held the third-largest share of the dental implant and final abutment market in China in 2024. The company maintained a strong market presence by investing in clinician training, collaborating with academic institution, and leveraging its extensive sales network. Nobel Biocare’s NobelActive® and NobelReplace® lines continued to drive growth, supported by proprietary technologies such as the NobelProcera® ASC abutment and Omnigrip tool. Envista also offers a comprehensive range of stock and CAD/CAM abutments for diverse clinical applications. Despite facing pricing pressure, the brand remains a preferred choice due to its quality, innovation and service. Looking ahead, Envista is expected to expand further through Nobel Biocare’s entry into the regenerative segment, with xenograft and allograft offerings complementing its implant portfolio.
MARKET SEGMENTATION SUMMARY
- Dental Implants Market – Further Segmented Into:
- Type: Premium, Value, Discount.
- Shape: Parallel Wall, Tapered.
- Material: Titanium, Ceramic/Zirconia.
- Procedure Type: One-stage, Two-stage, Immediate Loading.
- Connection Type: Internal Connection, External Connection, One-Piece.
- Application: Single-Tooth Application, Multi-Tooth Bridge Partial Arch Securement, Multi-Tooth Bridge Full Arch Securement, Denture Securement.
- Final Abutment Market – Further Segmented Into:
- Fabrication: Stock, Custom Cast, CAD/CAM.
- Material: Titanium, Ceramic/Zirconia, Gold.
- Type: Cement-Retained, Screw-Retained, Denture Retaining.
- Instrument Kit Market
- Treatment Planning Software Market
- Surgical Guide Market
RESEARCH SCOPE SUMMARY
| Report Attribute | Details |
|---|---|
| Regions | China |
| Base Year | 2024 |
| Forecast Period | 2025-2031 |
| Historical Data | 2021-2023 |
| Quantitative Data | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Data | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
